Incannex Clinical Trial Shows Notable Reduction In The Apnoea Hypopnoea Index With Novel Cannabinoid Product
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX: IHL),a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs, has completed of a preliminary analysis of data from its phase 2, proof-of-concept cl
